explore -WSS

explore

author：leisure time 2025-08-25 05:56:45 - browse：92432

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Poor hospice wound care hurts patients and families

WSS

Average age of first period drops to 11.9 years, study shows

Focused ultrasound for uterine fibroids: an uphill battle

David Sabatini, ex

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Gain of function research would be limited under House proposal

Morphosys mixed study results for blood cancer drug

explore

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Novavax promises a turnaround & Lilly roils the obesity market

Stigma and the return of syphilis

Activists slam private health insurers over coverage restrictions

Surge of respiratory disease in China has likely explanation

Sports medicine is finally prioritizing gender equality

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Cancer drug shortages should be causing more outrage

Surge of respiratory disease in China has likely explanation

knowledge

Addiction doctors spar with methadone clinics over legislation

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

U.K. considers world's first use of meningitis vaccine to address gonorrhea

FDA's Woodcock to retire early next year

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Weight loss drug costs may need more research, senator suggests

hotspot

entertainment

Wikipedia

focus